Medical cannabis investment company, Cilo Cybin Holdings Limited, listed today on the JSE’s AltX Board as a Special Purpose Acquisition vehicle (SPAC), with ambitions for significant future expansion and growth through new acquisitions in the biotechnology and medical cannabis industries.
“Embrace the highs, conquer the challenges. Each hurdle we overcome fuels our growth and strengthens our resolve. Together, we forge ahead, unwavering in our commitment to redefine possibilities and lead with innovation in the health and wellness industries,” Gabriel Theron, CEO and Founder of Cilo Cybin.
“We are pleased to welcome Cilo Cybin to our AltX Board which is a springboard for small and medium sized companies and catalyses their growth. With this listing, the JSE, is able to diversify its offering, presenting investors with unique, forward-looking opportunities. The addition of Cilo Cybin to the AltX underscores our commitment to embracing sectors poised for innovation, like medical cannabis and biotechnology,” said Valdene Reddy, Director of Capital Markets at the JSE.
More details here
